DD
D'Alessandro Danilo
Chief Financial Officer
OtherM
Insider track record
CFOAcross 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by D'Alessandro Danilo, Chief Financial Officer. Director active across 1 company, notably ClearPoint Neuro, Inc.. Aggregated, 20 reports have been recorded. Activity tracked since 20 August 2021. The latest transaction was filed on 31 December 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations20 total
16,313 sharesCommon StockSEC:0000950170-25-039498:0
4,146 sharesCommon StockSEC:0000950170-25-038954:0
18,765 sharesCommon StockSEC:0000950170-25-036672:0
1,949 shares@ US$4.532.6% of flowCommon StockSEC:0000950170-25-001315:0
1,191 shares@ US$11.263.7% of flowCommon StockSEC:0001285550-24-000103:0
1,913 shares@ US$4.582.5% of flowCommon StockSEC:0001285550-24-000088:0
4,824 shares@ US$5.748.0% of flowCommon StockSEC:0001285550-24-000081:0
9,383 shares0Common StockSEC:0001285550-24-000024:0
1,479 shares@ US$5.772.4% of flowCommon StockSEC:0001285550-24-000012:0
4,958 shares@ US$5.017.3% of flowCommon StockSEC:0001285550-23-000107:0
1,166 shares@ US$5.341.8% of flowCommon StockSEC:0001285550-23-000099:0
1,371 shares@ US$6.152.4% of flowCommon StockSEC:0001285550-23-000081:0
2,526 shares@ US$6.915.0% of flowCommon StockSEC:0001285550-23-000068:0
4,958 shares@ US$10.2316.0% of flowCommon StockSEC:0001285550-22-000056:0
583 shares@ US$13.242.4% of flowCommon StockSEC:0001285550-22-000049:0
23,400 shares0Common StockSEC:0001285550-22-000022:0
4,958 shares@ US$17.220.018% mcap50.0% of flowCommon StockSEC:0001420506-21-001354:0
4,958 shares@ US$17.2222.9% of flowCommon StockSEC:0001420506-21-001354
5,875 shares0Common StockSEC:0001420506-21-001339:0
5,875 shares0Common StockSEC:0001420506-21-001339
About D'Alessandro Danilo
Danilo D'Alessandro is the Chief Financial Officer at ClearPoint Neuro, Inc. He oversees the financial management of the company, including financial planning and reporting. His role is crucial for ensuring the financial health and growth of ClearPoint Neuro.